Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Scientists found that the 3D organization of DNA is disrupted in several types of brain cells affected by Alzheimer’s disease, altering how important genes are switched on and off. The discovery ...
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced ...
The FDA cleared the Elecsys Phospho-Tau (217P) Plasma blood test, which Roche and Lilly say is the single-biomarker blood test designed to test for the likelihood of amyloid pathology, a brain symptom ...
Learning you have early Alzheimer’s disease can bring up many emotions and questions about what comes next. While there isn’t a cure yet, treatment options have expanded in recent years. Some ...
New studies are shedding light on how the tests could eventually transform treatment. By Dana G. Smith and Pam Belluck Research presented this week at the Alzheimer’s Association International ...
A social media scam is using deepfakes of celebrities to promote products they falsely claim could cure Alzheimer’s disease and dementia, the Better Business Bureau warned. Some victims they even ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A supplement taken by millions of older adults to ease joint pain may ...
AlzeCure Pharma CEO Martin Jonsson and CSO Johan Sandin. (AlzeCure Pharma) Eli Lilly has signed a heavily backloaded agreement to license a gamma-secretase modulator treatment for Alzheimer's disease ...
Researchers have identified a new Alzheimer’s target and created an experimental compound that blocks a damaging process inside brain cells. In mice, the treatment slowed nerve cell loss, reduced ...
After a decade of cognitive and functional decline, an 80-year-old patient with advanced Alzheimer’s disease showed remarkable signs of progress. All it took was a single dose of an experimental ...
New research suggests eating one simple type of protein may lower the risk of Alzheimer’s disease. This isn’t the first study to make the connection. Experts say there could be a few reasons for this.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results